From 1 July 2025, there are new arrangements for the supply of measles-containing vaccines under the राष्ट्रीय टीकाकरण कार्यक्रम (NIP). Whereas previously both GSK and CLS supplied these vaccines, now only GSK will supply them.
Vaccine providers cannot place new orders for CSL’s M-M-R II (MMR) or Varivax (varicella). But existing stock should still be used until it either expires or runs out.
Providers can now only order GSK’s Priorix (MMR), Priorix-Tetra (MMR) and Varilrix (varicella).